Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Company News for May 20, 2025


  • Novavax Inc. (NVAX) shares jumped 15% after the company received a long-awaited U.S. FDA approval for its COVID-19 vaccine.
  • Shares of Regeneron Pharmaceuticals, Inc. (REGN) rose 0.4% after deciding to buy genomics firm 23andMe Holdings for $256 million through a bankruptcy auction.
  • Ryanair Holdings plc’s (RYAAY) climbed 7.9% after posting fourth-quarter fiscal 2025 adjusted loss-per-share of $0.59, narrower-than-the Zacks Consensus Estimate of a loss per share of $0.65.
  • Shares of ZIM Integrated Shipping Services Ltd. (ZIM) surged 5.7% after reporting first-quarter 2025 adjusted earnings per share of $2.45, surpassing the Zacks Consensus Estimate of $1.49.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ryanair Holdings PLC (RYAAY): Free Stock Analysis Report
 
Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report
 
Novavax, Inc. (NVAX): Free Stock Analysis Report
 
ZIM Integrated Shipping Services Ltd. (ZIM): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments